Product
BMS-986179
1 clinical trial
1 indication
Indication
Malignant Solid TumorClinical trial
A Phase 1/2a Study of BMS-986179 Administered Alone and in Combination With Nivolumab (BMS-936558) in Subjects With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2021-10-12